PROFESSOR HANS WIGZELL
CHAIRMAN OF THE BOARD
Professor of Immunology, Karolinska Institute. Former Vice-Chancellor of Karolinska Institute, Head of the Swedish Institute for Infectious Disease Control, the National Swedish Bacteriological Laboratory and Chair of the Nobel Committee for the Karolinska Institute. Member of the Royal Swedish Academy of Sciences, and the Royal Swedish Academy of Engineering Sciences IVA.
Total number of board appointments: 5
BIRGITTA STYMNE GÖRANSSON
Master of Science in Biotechnology, Royal Institute of Technology, (KTH) and MBA Harvard Business School.
Board Director in Elekta, Capio, Midsona, Sophiahemmet and Chairman of the Boards of HL Display and Fryshuset foundation. Industrial advisor within healthcare, consumer products and technology.
Several CEO and senior management positions in Swedish industry; e.g. CEO of Memira Group, COO of Telefos, management consultant at McKinsey, product manager Gambro.
Total number of board appointments: 7
Honorary Doctorate in Medicine and Bachelor of Science in Economics. Chair of Affibody Medical AB, PledPharma and 20 North Street (RP) AB. Former Chair of Swedish Orphan Biovitrum AB (SOBI), Orexo AB and Ferrosan AS. CEO of Pharmacia Kabi and Astra Pharmaceutical Ltd. Several other leading positions in the pharmaceutical industry
Total number of board appointments: 6
Founder and CEO, Rhenman & Partners. Former Head of Private Banking, Kaupthing Bank Sweden. Head of Private Banking, Kaupthing Bank Sweden. Managing Director, Carnegie Asset Management. Managing Director, Carnegie Pension Consulting. Deputy Managing Director, Montague Midland Bank / HSBC. Portfolio Manager, Handelsbanken Asset Management. Tax Expert, Stockholm County Administrative Board.
Total number of board appointments: 3
Biochemist, Royal Institute of Technology, Bachelor of Science, Stockholm School of Economics. Founder and Chief Investment Officer, Rhenman & Partners. Former Founder & CIO, Carnegie Healthcare Funds, Carnegie Investment Bank. Managing Director, Portfolio Manager, SG Cowen, Boston. Portfolio Manager, SEB Pharmaceutical Fund. Chief Analyst, Hagströmer & Qviberg
Total number of board appointments: 2
Founder and Head of Investor Relations, Rhenman & Partners. Former Portfolio Manager, Carnegie Investment Bank, Stockholm. Founding Partner and Portfolio Manager, Absolute Plus, Zurich. Equity Analyst, ABG Sundal Collier, London and Zurich. Portfolio Strategist, Fidelity Investments, Luxembourg and London